Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blind

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pathology|April 7, 2007
Antigenicity testing by immunohistochemistry after tissue oxidationC Blind, A Koepenik, M Pacyna-Gengelbach, et al.
European Urology|December 26, 2001
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrenceM G Friedrich, C Blind, K Milde-Langosch, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pathology|April 7, 2007
Antigenicity testing by immunohistochemistry after tissue oxidationC Blind, A Koepenik, M Pacyna-Gengelbach, et al.
European Urology|December 26, 2001
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrenceM G Friedrich, C Blind, K Milde-Langosch, et al.
Pageof 1